{"id":1048500,"date":"2012-02-22T04:54:12","date_gmt":"2012-02-22T04:54:12","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/uncategorized\/rapid-tests-and-point-of-care-market-to-2017-clinical-chemistry-tests-to-be-the-major-revenue-generator.php"},"modified":"2024-08-17T17:56:14","modified_gmt":"2024-08-17T21:56:14","slug":"rapid-tests-and-point-of-care-market-to-2017-clinical-chemistry-tests-to-be-the-major-revenue-generator","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/chemistry\/rapid-tests-and-point-of-care-market-to-2017-clinical-chemistry-tests-to-be-the-major-revenue-generator.php","title":{"rendered":"Rapid Tests and Point of Care Market to 2017 &#8211; Clinical Chemistry Tests to be the Major Revenue Generator"},"content":{"rendered":"<p><p>    NEW YORK, Feb. 21, 2012 \/PRNewswire\/ -- Reportlinker.com    announces that a new market research report is available in its    catalogue:  <\/p>\n<p class=\"c1\">    Rapid Tests and Point of Care Market to 2017 -    Clinical Chemistry Tests to be the Major Revenue Generator  <\/p>\n<p>    <a href=\"http:\/\/www.reportlinker.com\/p0778001\/Rapid-Tests-and-Point-of-Care-Market-to-2017---Clinical-Chemistry-Tests-to-be-the-Major-Revenue-Generator.html#utm_source=prnewswire&#038;utm_medium=pr&#038;utm_campaign=In_Vitro_Diagnostic\" rel=\"nofollow\">http:\/\/www.reportlinker.com\/p0778001\/Rapid-Tests-and-Point-of-Care-Market-to-2017---Clinical-Chemistry-Tests-to-be-the-Major-Revenue-Generator.html#utm_source=prnewswire&#038;utm_medium=pr&#038;utm_campaign=In_Vitro_Diagnostic<\/a>  <\/p>\n<p>    Rapid    Tests and Point of Care Market to 2017 -    Clinical Chemistry Tests to be the Major Revenue Generator  <\/p>\n<p class=\"c1\">    Summary  <\/p>\n<p>    GBI Research&#039;s report, \"Rapid Tests and Point of Care Market to    2017 - Clinical Chemistry Tests to be the Major Revenue    Generator\", provides key data, information and analysis on the    global rapid tests and point of care (POC) market. The report    provides information on the market landscape, the competitive    landscape and market trend information on three rapid tests and    POC market categories: clinical chemistry rapid tests and POC,    immunochemistry rapid tests, and hematology rapid tests. The    report provides comprehensive information on the key trends    affecting these categories and key analytical content on the    market&#039;s dynamics. The report also provides profiles of the    major companies operating in the rapid tests and POC market and    a detailed analysis of the pipeline products in each category.    Furthermore, the report reviews the details of important merger    and acquisition deals that have taken place in the rapid tests    and POC market over the past four years. The report is compiled    using data and information sourced from proprietary databases,    primary and secondary research, and in-house analysis by GBI    Research&#039;s team of industry experts.  <\/p>\n<p class=\"c1\">    Scope  <\/p>\n<p>    - Key geographies covered include the US, Canada, the UK,    Germany, France, Italy, Spain, Japan, China, India, Australia    and Brazil.  <\/p>\n<p>    - The market size of three rapid tests and POC market    categories - clinical chemistry rapid tests and POC,    immunochemistry rapid tests, and hematology rapid tests.  <\/p>\n<p>    - Annualized market revenue data from 2003 to 2010, forecast    forward for 7 years to 2017.  <\/p>\n<p>    - Qualitative analysis of key market trends, market drivers and    restraints of each category within the rapid tests and POC    market.  <\/p>\n<p>    - The report also covers information on the leading players in    the market and the leading technologies.  <\/p>\n<p class=\"c1\">    Reasons to buy  <\/p>\n<p>    - Develop business strategies by understanding the trends and    developments that are driving the global rapid tests and POC    market.  <\/p>\n<p>    - Design and develop your product&#039;s development, marketing and    sales strategies.  <\/p>\n<p>    - Exploit M&amp;A opportunities by identifying market the    players with the most innovative pipeline.  <\/p>\n<p>    - Develop market entry and market expansion strategies.  <\/p>\n<p>    - Identify the key players best positioned to take advantage of    emerging market opportunities.  <\/p>\n<p>    - Exploit in-licensing and out-licensing opportunities by    identifying the products most likely to ensure a robust return.  <\/p>\n<p>    - What&#039;s the next big thing in the rapid tests and POC market    landscape? Identify, understand and capitalize.  <\/p>\n<p>    - Make more informed business decisions with the aid of    insightful and in-depth analysis of the global rapid tests and    POC market and the factors shaping it.  <\/p>\n<p>    1 Table of Contents1 Table of Contents 31.1 List of Tables 61.2    List of Figures 72 Introduction 82.1 GBI Research Guidance 93    Global Rapid Tests and Point of Care Market - Market    Characterization 103.1 Global Rapid Tests and Point of Care    Market, Revenue ($m), 2003 - 2010 103.2 Global Rapid Tests and    Point of Care Market, Revenue ($m), 2010 - 2017 113.3 Global    Rapid Tests and Point of Care Market, Key Market Trends 123.3.1    Decentralization of Laboratories is a Growing Trend Across the    World 123.3.2 Integration of POC Devices with Hospital    Information Systems is a Growing Trend 123.4 Significant    Consolidation in Recent Years to Reshape the Competitive    Landscape of the Industry 133.4.1 Increased Demand for Rapid    Tests and POC Testing in Emerging Countries Will Drive the    Growth of the Market in the Near Future 133.5 Global Rapid    Tests and Point of Care, Market Dynamics 143.5.1 Global Rapid    Tests and Point of Care, Market Drivers 143.5.2 Global Rapid    Tests and Point of Care, Market Restraints 164 Global Rapid    Tests and Point of Care Market - Market Category Analysis and    Forecasts 184.1 Clinical Chemistry Rapid Tests and POC 184.1.1    Clinical    Chemistry Rapid Tests and POC Market, Global, Revenue    ($m), 2003 - 2010 184.1.2 Clinical Chemistry Rapid Tests and    POC Market, Global, Revenue Forecasts ($m), 2010 - 2017 204.2    Clinical Chemistry Rapid Tests and POC Market - Market Dynamics    214.2.1 Clinical Chemistry Rapid Tests and POC Market - Market    Drivers 214.2.2 Clinical Chemistry Rapid Tests and POC Market -    Market Restraints 224.3 Immunochemistry Rapid Tests Market    234.3.1 Immunochemistry Rapid Tests Market, Global, Revenue    ($m), 2003 - 2010 234.3.2 Immunochemistry Rapid Tests Market,    Global, Revenue Forecasts ($m), 2010 - 2017 244.4    Immunochemistry Rapid Tests Market - Market Dynamics 254.4.1    Immunochemistry Rapid Tests Market - Market Drivers 254.4.2    Immunochemistry Rapid Tests Market - Market Restraints 264.5    Hematology Rapid Tests Market 264.5.1 Hematology Rapid Tests    Market, Global, Revenue ($m), 2003 - 2010 274.5.2 Hematology Rapid Tests    Market, Global, Revenue Forecasts ($m), 2010 - 2017    284.6 Hematology Rapid Tests Market - Market Dynamics 294.6.1    Hematology Rapid Tests Market - Market Drivers 294.6.2    Hematology Rapid Tests Market - Market Restraints 305 Global    Rapid Tests and Point of Care Market - Country Analysis and    Forecasts 315.1 Rapid Tests and Point of Care Market - Cross -    Country Analysis 315.2 Revenue Forecasts, by Country, 2003 -    2017 335.2.1 Rapid Tests and Point of Care Market, the US,    Revenue ($m), 2003 - 2010 335.2.2 Rapid Tests and Point of Care    Market, the US, Revenue ($m), 2010 - 2017 345.2.3 Rapid Tests    and Point of Care Market, Canada, Revenue ($m), 2003 - 2010    355.2.4 Rapid Tests and Point of Care Market, Canada, Revenue    ($m), 2010 - 2017 365.2.5 Rapid Tests and Point of Care Market,    the UK, Revenue ($m), 2003 - 2010 375.2.6 Rapid Tests and Point    of Care Market, the UK, Revenue ($m), 2010 - 2017 385.2.7 Rapid    Tests and Point of Care Market, Germany, Revenue ($m), 2003 -    2010 395.2.8 Rapid Tests and Point of Care Market, Germany,    Revenue ($m), 2010 - 2017 405.2.9 Rapid Tests and Point of Care    Market, France, Revenue ($m), 2003 - 2010 415.2.10 Rapid Tests    and Point of Care Market, France, Revenue ($m), 2010 - 2017    425.2.11 Rapid Tests and Point of Care Market, Italy, Revenue    ($m), 2003 - 2010 435.2.12 Rapid Tests and Point of Care    Market, Italy, Revenue ($m), 2010 - 2017 445.2.13 Rapid Tests    and Point of Care Market, Spain, Revenue ($m), 2003 - 2010    455.2.14 Rapid Tests and Point of Care Market, Spain, Revenue    ($m), 2010 - 2017 465.2.15 Rapid Tests and Point of Care    Market, Japan, Revenue ($m), 2003 - 2010 475.2.16 Rapid Tests    and Point of Care Market, Japan, Revenue ($m), 2010 - 2017    485.2.17 Rapid Tests and Point of Care Market, China, Revenue    ($m), 2003 - 2010 495.2.18 Rapid Tests and Point of Care    Market, China, Revenue ($m), 2010 - 2017 505.2.19 Rapid Tests    and Point of Care Market, India, Revenue ($m), 2003 - 2010    515.2.20 Rapid Tests and Point of Care Market, India, Revenue    ($m), 2010 - 2017 525.2.21 Rapid Tests and Point of Care    Market, Australia, Revenue ($m), 2003 - 2010 535.2.22 Rapid    Tests and Point of Care Market, Australia<br \/>\n, Revenue ($m), 2010 -    2017 545.2.23 Rapid Tests and Point of Care Market, Brazil,    Revenue ($m), 2003 - 2010 555.2.24 Rapid Tests and Point of    Care Market, Brazil, Revenue ($m), 2010 - 2017 566 Global Rapid    Tests and Point of Care Market - Key Market Participants 576.1    F. Hoffmann - La Roche Ltd. 576.1.1 Business Overview 576.1.2    Marketed Products 576.2 Abbott Laboratories 576.2.1 Business    Overview 576.2.2 Marketed products 586.3 Siemens Healthcare    (Subsidiary of Siemens AG) 586.3.1 Business Overview 586.3.2    Marketed Products 586.4 Beckman Coulter, Inc. (Subsidiary of    Danaher Corporation) 596.4.1 Business Overview 596.4.2 Marketed    Products: 596.5 bioMerieux S.A. (Subsidiary of Merieux Alliance    Group) 606.5.1 Business Overview 606.5.2 Marketed products    606.6 DiaSorin S.p.A 606.6.1 Business Overview 606.6.2 Marketed    Products: 617 Global Rapid Tests and Point of Care Market -    Product Pipeline Analysis 627.1 Rapid Tests and Point of Care    Market - Pipeline Product Summary 627.2 Rapid Tests and Point    of Care Market - List of Pipeline Products 647.3 Rapid Tests    and Point of Care - Profiles of Key Pipeline Products 667.3.1    ImmProCon Technology 667.3.2 RAPIDPoint 500 System - Lactate    Assay 667.3.3 Sali - Chek Reader 667.3.4 Point Of Care    Diagnostic Device 677.3.5 ACE Alera Clinical Chemistry System -    Direct A1c Assay 677.3.6 Advia 120 Hematology System - IRF Test    677.3.7 Advia 2120 Hematology System - MPC Test 687.3.8 AIA -    600 II - D - dimer Test 688 Global Rapid Tests and Point of    Care Market - Consolidation Landscape 698.1 Rapid Tests and    Point of Care Market - Key Deals 2011 698.1.1 Sony Corporation    of America Acquires Micronics 698.1.2 Roche Completes    Acquisition of MTM Laboratories 698.1.3 Quest Diagnostics    Completes Acquisition of Athena Diagnostics 698.1.4 Danaher    Completes Acquisition of Beckman Coulter 708.2 Rapid Tests and    Point of Care Market - Key Deals, 2007 - 2010 708.2.1 Merck    Completes Acquisition of Millipore 708.2.2 Inverness Medical    Innovations Acquires 78.13% Stake in Standard Diagnostics    718.2.3 Inverness Medical Innovations Completes Acquisition of    Concateno from Marwyn 718.2.4 bioMerieux Acquires AviaraDx    718.2.5 Siemens Medical Acquires Dade Behring 718.2.6 Roche    Acquires Ventana Medical Systems 728.2.7 Bio - Rad Laboratories    Acquires Diamed 729 Appendix 739.1 Definitions 739.1.1 Clinical    Chemistry Rapid Tests &amp; POC 739.1.2 Immunochemistry Rapid    Tests Market 739.1.3 Haematology Rapid Tests Market 739.2    Acronyms 739.3 Research Methodology 749.3.1 Secondary Research    749.3.2 Primary Research 749.3.3 Models 759.3.4 Forecasts    759.3.5 Expert Panels 759.4 Contact Us 759.5 Disclaimer 769.6    Sources 76  <\/p>\n<p class=\"c1\">    1.1 List of Tables  <\/p>\n<p>    Table 1: Rapid Tests and Point of Care Market, Global, Revenue    ($m), 2003 - 2010 10Table 2: Rapid Tests and Point of Care    Market, Global, Revenue ($m), 2010 - 2017 11Table 3: Clinical    Chemistry Rapid Tests and POC Market, Global, Revenue ($m),    2003 - 2010 19Table 4: Clinical Chemistry Rapid Tests and POC    Market, Global, Revenue ($m), 2010 - 2017 20Table 5:    Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003    - 2010 23Table 6: Immunochemistry Rapid Tests Market, Global,    Revenue ($m), 2010 - 2017 24Table 7: Hematology Rapid Tests    Market, Global, Revenue ($m), 2003 - 2010 27Table 8: Hematology    Rapid Tests Market, Global, Revenue ($m), 2010 - 2017 28Table    9: Rapid Tests and Point of Care Market, Global, Cross Country    Analysis, CAGR (%), 2003 - 2017 31Table 10: Rapid Tests and    Point of Care Market, the US, Revenue ($m), 2003 - 2010 33Table    11: Rapid Tests and Point of Care Market, the US, Revenue ($m),    2010 - 2017 34Table 12: Rapid Tests and Point of Care Market,    Canada, Revenue ($m), 2003 - 2010 35Table 13: Rapid Tests and    Point of Care Market, Canada, Revenue ($m), 2010 - 2017 36Table    14: Rapid Tests and Point of Care Market, the UK, Revenue ($m),    2003 - 2010 37Table 15: Rapid Tests and Point of Care Market,    the UK, Revenue ($m), 2010 - 2017 38Table 16: Rapid Tests and    Point of Care Market, Germany, Revenue ($m), 2003 - 2010    39Table 17: Rapid Tests and Point of Care Market, the Germany,    Revenue ($m), 2010 - 2017 40Table 18: Rapid Tests and Point of    Care Market, France, Revenue ($m), 2003 - 2010 41Table 19:    Rapid Tests and Point of Care Market, France, Revenue ($m),    2010 - 2017 42Table 20: Rapid Tests and Point of Care Market,    Italy, Revenue ($m), 2003 - 2010 43Table 21: Rapid Tests and    Point of Care Market, Italy, Revenue ($m), 2010 - 2017 44Table    22: Rapid Tests and Point of Care Market, Spain, Revenue ($m),    2003 - 2010 45Table 23: Rapid Tests and Point of Care Market,    Spain, Revenue ($m), 2010 - 2017 46Table 24: Rapid Tests and    Point of Care Market, Japan, Revenue ($m), 2003 - 2010 47Table    25: Rapid Tests and Point of Care Market, Japan, Revenue ($m),    2010 - 2017 48Table 26: Rapid Tests and Point of Care Market,    China, Revenue ($m), 2003 - 2010 49Table 27: Rapid Tests and    Point of Care Market, China, Revenue ($m), 2010 - 2017 50Table    28: Rapid Tests and Point of Care Market, India, Revenue ($m),    2003 - 2010 51Table 29: Rapid Tests and Point of Care Market,    India, Revenue ($m), 2010 - 2017 52Table 30: Rapid Tests and    Point of Care Market, Australia, Revenue ($m), 2003 - 2010    53Table 31: Rapid Tests and Point of Care Market, Australia,    Revenue ($m), 2010 - 2017 54Table 32: Rapid Tests and Point of    Care Market, Brazil, Revenue ($m), 2003-2010 55Table 33: Rapid    Tests and Point of Care Market, Brazil, Revenue ($m), 2010 -    2017 56Table 34: Rapid Tests and Point of Care Market, Global,    Pipeline Product Summary, 2010 62Table 35: Rapid Tests and    Point of Care Market, Pipeline Assessment, by Development Stage    63Table 36: Rapid Tests and Point of Care Market, Global, List    of Pipeline Products, 2010 - 2011 64Table 37: Rapid Test and    Point of Care Market, Global, List of Pipeline Products, 2010 -    2012 65Table 38: ImmProCon Technology, Product Status, 2011    66Table 39: RAPIDPoint 500 System, Product Status, 2011 66Table    40: Sali - Chek Reader, Product Status, 2011 66Table 41: Point    Of Care Diagnostic Device, Product Status, 2011 67Table 42: ACE    Alera Clinical Chemistry System - Direct A1c Assay, Product    Status, 2011 67Table 43: Advia 120 Hematology System - IRF    (Immature Reticulocyte Fraction) Test, Product Status, 2011    67Table 44: Advia 2120 Hematology System - MPC (Mean Platelet    Component) Test, Product Status, 2011 68Table 45: AIA    (Automated Immunoassay Analyzer) - 600 II - D - dimer Test,    Product Status, 2011 68  <\/p>\n<p class=\"c1\">    1.2 List of Figures  <\/p>\n<p>    Figure 1: Rapid Tests and Point of Care Market, Global, Revenue    ($m), 2003 - 2010 10Figure 2: Rapid Tests and Point of Care    Market, Global, Revenue ($m), 2010 - 2017 11Figure 3: Rapid    Tests and Point of Care Market, Market Categorization and    Segmentation 18Figure 4: Clinical Chemistry Rapid Tests and POC    Market, Global, Revenue ($m), 2003 - 2010 18Figure 5: Clinical    Chemistry Rapid Tests and POC Market, Global, Revenue ($m),    2010 - 2017 20Figure 6: Immunochemistry Rapid Tests Market,    Global, Revenue ($m), 2003 - 2010 23Figure 7: Immunochemistry    Rapid Tests Market, Global, Revenue ($m), 2010 - 2017 24Figure    8: Hematology Rapid Tests Market, Global, Revenue ($m), 2003 -    2010 27Figure 9: Hematology Rapid Tests Market, Global, Revenue    ($m), 2010 - 2017 28Figure 10: Rapid Tests and Point of Care    Market, Global, Cross Country Analysis, CAGR (%), 2003 - 2017    31Figure 11: Rapid Tests and Point of Care Market, the US,    Revenue ($m), 2003 - 2010 33Figure 12: Rapid Tests and Point of    Care Market, the US, Revenue ($m), 2010 - 2017 34Figure 13:    Rapid Tests and Point of Care Market, Canada, Revenue ($m),    2003 - 2010 35Figure 14: Rapid Tests and Point of Care Market,    Canada, Revenue ($m), 2010 - 2017 36Figure 15: Rapid Tests and    Point of Care Market, the<br \/>\nUK, Revenue ($m), 2003 - 2010    37Figure 16: Rapid Tests and Point of Care Market, the UK,    Revenue ($m), 2010 - 2017 38Figure 17: Rapid Tests and Point of    Care Market, Germany, Revenue ($m), 2003 - 2010 39Figure 18:    Rapid Tests and Point of Care Market, Germany, Revenue ($m),    2010 - 2017 40Figure 19: Rapid Tests and Point of Care Market,    France, Revenue ($m), 2003 - 2010 41Figure 20: Rapid Tests and    Point of Care Market, France, Revenue ($m), 2010 - 2017    42Figure 21: Rapid Tests and Point of Care Market, Italy,    Revenue ($m), 2003 - 2010 43Figure 22: Rapid Tests and Point of    Care Market, Italy, Revenue ($m), 2010 - 2017 44Figure 23:    Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2003    - 2010 45Figure 24: Rapid Tests and Point of Care Market,    Spain, Revenue ($m), 2010 - 2017 46Figure 25: Rapid Tests and    Point of Care Market, Japan, Revenue ($m), 2003 - 2010 47Figure    26: Rapid Tests and Point of Care Market, Japan, Revenue ($m),    2010 - 2017 48Figure 27: Rapid Tests and Point of Care Market,    China, Revenue ($m), 2003 - 2010 49Figure 28: Rapid Tests and    Point of Care Market, China, Revenue ($m), 2010 - 2017 50Figure    29: Rapid Tests and Point of Care Market, India, Revenue ($m),    2003 - 2010 51Figure 30: Rapid Tests and Point of Care Market,    India, Revenue ($m), 2010 - 2017 52Figure 31: Rapid Tests and    Point of Care Market, Australia, Revenue ($m), 2003 - 2010    53Figure 32: Rapid Tests and Point of Care Market, Australia,    Revenue ($m), 2010 - 2017 54Figure 33: Rapid Tests and Point of    Care Market, Brazil, Revenue ($m), 2003-2010 55Figure 34: Rapid    Tests and Point of Care Market, Brazil, Revenue ($m), 2010 -    2017 56Figure 35: Rapid Tests and Point of Care Market, Global,    Pipeline Product Summary (%), 2010 62Figure 36: Rapid Tests and    Point of Care Market, Pipeline Assessment, by Development Stage    63  <\/p>\n<p class=\"c1\">    Companies mentioned  <\/p>\n<p>    F. Hoffmann - La Roche Ltd.  <\/p>\n<p>    Abbott Laboratories  <\/p>\n<p>    Siemens Healthcare (Subsidiary of Siemens AG)  <\/p>\n<p>    Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)  <\/p>\n<p>    bioMerieux S.A. (Subsidiary of Merieux Alliance Group)  <\/p>\n<p>    DiaSorin S.p.A  <\/p>\n<p>    To order this report:In Vitro Diagnostic Industry: Rapid Tests and Point of Care Market to 2017 -    Clinical Chemistry Tests to be the Major Revenue Generator  <\/p>\n<p>    More&nbsp;&nbsp;Market Research Report  <\/p>\n<p>    Check our&nbsp;&nbsp;Industry Analysis and Insights  <\/p>\n<p>    Nicolas Bombourg<br \/>    Reportlinker<br \/>    Email:     <a href=\"mailto:nbo@reportlinker.com\">nbo@reportlinker.com<\/a><br \/>    US: (805)652-2626<br \/>    Intl: +1 805-652-2626  <\/p>\n<\/p>\n<p>More here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/rapid-tests-point-care-market-123300012.html\" title=\"Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator\" rel=\"noopener\">Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> NEW YORK, Feb. 21, 2012 \/PRNewswire\/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator <a href=\"http:\/\/www.reportlinker.com\/p0778001\/Rapid-Tests-and-Point-of-Care-Market-to-2017---Clinical-Chemistry-Tests-to-be-the-Major-Revenue-Generator.html#utm_source=prnewswire&#038;utm_medium=pr&#038;utm_campaign=In_Vitro_Diagnostic\" rel=\"nofollow\">http:\/\/www.reportlinker.com\/p0778001\/Rapid-Tests-and-Point-of-Care-Market-to-2017---Clinical-Chemistry-Tests-to-be-the-Major-Revenue-Generator.html#utm_source=prnewswire&#038;utm_medium=pr&#038;utm_campaign=In_Vitro_Diagnostic<\/a> Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator Summary GBI Research&#039;s report, \"Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator\", provides key data, information and analysis on the global rapid tests and point of care (POC) market <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/chemistry\/rapid-tests-and-point-of-care-market-to-2017-clinical-chemistry-tests-to-be-the-major-revenue-generator.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246863],"tags":[],"class_list":["post-1048500","post","type-post","status-publish","format-standard","hentry","category-chemistry"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1048500"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1048500"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1048500\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1048500"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1048500"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1048500"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}